Hub : Traits :

Illnesses of siblings

9 significantly associated models · 7 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	3	47681881	49016056	1	1	2.4e-07	6.7e-06	0.958	100	FCF1P2
2	4	2389800	3943984	1	1	5.7e-08	2.6e-06	0.024	77	HTT
3	15	91181489	91686147	1	1	2.0e-07	5.2e-07	1.000	100	FES
4	16	86671	1032776	1	1	2.9e-07	6.1e-06	0.749	100	PDIA2
5	16	30347731	31833122	2	1	5.7e-08	5.5e-08	1.000	100	KAT8
6	16	53226098	53759123	1	1	2.2e-07	1.2e-05	0.189	91	RBL2

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Vascular/heart problems diagnosed by doctor	17.30	5	3	6.7	0.94	0.01622	FCF1P2 FES KAT8 PDIA2 RBL2
Hypertension (Self-reported)	15.77	5	4	8.9	-0.94	0.01739	FCF1P2 FES KAT8 PDIA2 RBL2
High blood pressure	15.52	5	3	6.7	-0.94	0.01586	FCF1P2 FES KAT8 PDIA2 RBL2
Cardiovascular Disease	15.24	6	4	8.9	-0.95	0.00323	FCF1P2 FES HTT KAT8 PDIA2 RBL2
High blood pressure (siblings)	14.79	6	2	4.4	-0.99	0.00023	FCF1P2 FES HTT KAT8 PDIA2 RBL2
Systolic Blood Pressure	12.98	3	2	4.4	0.00	1.00000	FCF1P2 FES PDIA2
High blood pressure (mother)	11.63	1	1	2.2	0.00	1.00000	FES
Diastolic blood pressure, automated reading	11.29	4	3	6.7	-0.95	0.05270	FCF1P2 FES KAT8 PDIA2
Systolic blood pressure, automated reading	10.58	4	1	2.2	-0.92	0.08306	FCF1P2 FES KAT8 PDIA2
Medication: Blood pressure	10.20	4	1	2.2	-0.99	0.00556	FCF1P2 FES KAT8 RBL2
Medication for cholesterol, blood pressure or diabetes	10.19	3	1	2.2	0.00	1.00000	FCF1P2 FES KAT8
Medication: Blood pressure	10.07	3	1	2.2	0.00	1.00000	FCF1P2 FES KAT8
Illnesses of father: High blood pressure	7.85	1	1	2.2	0.00	1.00000	FES
Heart disease (siblings)	7.69	2	0	0.0	0.00	1.00000	FES PDIA2
Overall health rating	7.59	4	2	4.4	-0.98	0.01842	HTT KAT8 PDIA2 RBL2
Body mass index (BMI)	7.27	3	3	6.7	0.00	1.00000	HTT KAT8 PDIA2
Medication: Atenolol	7.13	1	1	2.2	0.00	1.00000	FES
Illnesses of father: None of the above (group 1)	7.00	1	1	2.2	0.00	1.00000	FES
Medication: Cholesterol lowering	6.98	2	1	2.2	0.00	1.00000	FES KAT8
Illnesses of mother	6.98	1	1	2.2	0.00	1.00000	FES
Hip circumference	6.96	4	3	6.7	-0.53	0.47009	HTT KAT8 PDIA2 RBL2
Waist circumference	6.93	3	3	6.7	0.00	1.00000	HTT KAT8 PDIA2
Arm fat percentage (left)	6.89	3	3	6.7	0.00	1.00000	HTT KAT8 PDIA2
Arm fat mass (left)	6.89	4	3	6.7	-0.72	0.27724	HTT KAT8 PDIA2 RBL2
Medication for cholesterol	6.88	4	0	0.0	0.99	0.00810	FCF1P2 FES KAT8 RBL2
Arm fat mass (right)	6.63	4	3	6.7	-0.73	0.26936	HTT KAT8 PDIA2 RBL2
Arm fat percentage (right)	6.60	3	3	6.7	0.00	1.00000	HTT KAT8 PDIA2
Birth weight of first child	6.54	2	1	2.2	0.00	1.00000	FES RBL2
Leg fat percentage (left)	6.45	4	3	6.7	-0.97	0.03301	HTT KAT8 PDIA2 RBL2
Illnesses of father: Heart disease	6.35	1	1	2.2	0.00	1.00000	FES
Medication: Simvastatin	6.28	2	1	2.2	0.00	1.00000	FES KAT8
Angina (self-reported)	6.21	1	1	2.2	0.00	1.00000	FES
Leg fat mass (left)	6.11	3	3	6.7	0.00	1.00000	HTT KAT8 PDIA2
Medication: Aspirin	6.08	1	1	2.2	0.00	1.00000	FES
Father's age at death	6.07	1	1	2.2	0.00	1.00000	FES
Angina	6.03	1	1	2.2	0.00	1.00000	FES
Leg fat percentage (right)	6.00	4	3	6.7	-0.97	0.02821	HTT KAT8 PDIA2 RBL2
Leg fat mass (right)	5.94	3	3	6.7	0.00	1.00000	HTT KAT8 PDIA2
Whole body fat mass	5.83	3	3	6.7	0.00	1.00000	HTT KAT8 PDIA2
Body fat percentage	5.74	3	3	6.7	0.00	1.00000	HTT KAT8 PDIA2
Weight	5.63	4	3	6.7	-0.58	0.42263	HTT KAT8 PDIA2 RBL2
Medication: Amlodipine	5.52	1	1	2.2	0.00	1.00000	FES
Medication: Aspirin	5.48	1	1	2.2	0.00	1.00000	FES
Number of self-reported non-cancer illnesses	5.40	4	0	0.0	-1.00	0.00259	FCF1P2 FES PDIA2 RBL2
Type 2 Diabetes (T2D) (2018)	5.27	4	0	0.0	-0.97	0.02771	HTT KAT8 PDIA2 RBL2
BMI	5.24	3	2	4.4	0.00	1.00000	HTT KAT8 PDIA2
Medication: Bendroflumethiazide	5.23	2	0	0.0	0.00	1.00000	FES KAT8
Trunk fat mass	5.21	3	3	6.7	0.00	1.00000	HTT KAT8 PDIA2
Trunk fat percentage	5.10	3	3	6.7	0.00	1.00000	HTT KAT8 PDIA2
Birth weight	5.09	2	1	2.2	0.00	1.00000	FES PDIA2
Leg fat-free mass (right)	5.03	4	2	4.4	0.07	0.92581	FES KAT8 PDIA2 RBL2
Leg predicted mass (right)	4.98	5	2	4.4	-0.03	0.95664	FES HTT KAT8 PDIA2 RBL2
Leg fat-free mass (left)	4.96	5	2	4.4	-0.07	0.90776	FES HTT KAT8 PDIA2 RBL2
Leg predicted mass (left)	4.93	5	2	4.4	-0.07	0.90769	FES HTT KAT8 PDIA2 RBL2
Number of incorrect matches in round	4.91	2	1	2.2	0.00	1.00000	FES KAT8
Number of treatments/medications taken	4.89	4	0	0.0	-1.00	0.00083	FCF1P2 FES KAT8 PDIA2
Illnesses of siblings: Diabetes	4.83	2	0	0.0	0.00	1.00000	HTT PDIA2
Financial difficulties in last 2 years	4.80	2	0	0.0	0.00	1.00000	KAT8 PDIA2
Alzheimer’s Disease (including proxy)	4.71	1	1	2.2	0.00	1.00000	KAT8
Verbal and Numeric Reasoning (VNR)	4.71	1	1	2.2	0.00	1.00000	RBL2
Fluid intelligence score	4.67	1	1	2.2	0.00	1.00000	RBL2
Alcohol intake frequency.	4.60	2	1	2.2	0.00	1.00000	HTT KAT8
Intelligence (Savage-Jansen 2018)	4.49	1	1	2.2	0.00	1.00000	RBL2
Diabetes diagnosed by doctor	4.49	2	0	0.0	0.00	1.00000	PDIA2 RBL2
Impedance of leg (right)	4.44	4	2	4.4	-0.08	0.92026	FES KAT8 PDIA2 RBL2
Qualifications: College or University degree	4.42	4	1	2.2	0.94	0.06194	HTT KAT8 PDIA2 RBL2
Heart attack	4.40	1	0	0.0	0.00	1.00000	FES
Heart attack/myocardial infarction (self-reported)	4.38	1	0	0.0	0.00	1.00000	FES
Pulse wave peak to peak time	4.37	3	0	0.0	0.00	1.00000	FES KAT8 RBL2
Diabetes (self-reported)	4.31	1	0	0.0	0.00	1.00000	RBL2
Impedance of leg (left)	4.29	4	2	4.4	-0.11	0.88698	FES KAT8 PDIA2 RBL2
Medication: Lisinopril	4.23	2	0	0.0	0.00	1.00000	FCF1P2 FES
Basal metabolic rate	4.21	3	2	4.4	0.00	1.00000	KAT8 PDIA2 RBL2
Knee pain experienced in last month	4.20	2	0	0.0	0.00	1.00000	KAT8 PDIA2
Pain experienced in last month	4.16	2	0	0.0	0.00	1.00000	KAT8 PDIA2
Wheeze or whistling in the chest in last year	4.11	2	0	0.0	0.00	1.00000	HTT KAT8
Cholesterol lowering medication	4.03	2	0	0.0	0.00	1.00000	KAT8 RBL2
Age at first live birth	4.01	3	0	0.0	0.00	1.00000	HTT KAT8 RBL2
High cholesterol (Self-reported)	3.97	2	0	0.0	0.00	1.00000	FES KAT8
Triglycerides	3.79	1	1	2.2	0.00	1.00000	KAT8
Whole body water mass	3.75	3	2	4.4	0.00	1.00000	KAT8 PDIA2 RBL2
Unable to work because of sickness or disability	3.75	2	0	0.0	0.00	1.00000	HTT KAT8
Schizophrenia (2018)	3.69	2	1	2.2	0.00	1.00000	FCF1P2 FES
Pulse wave Arterial Stiffness index	3.69	2	0	0.0	0.00	1.00000	FES KAT8
Whole body fat-free mass	3.69	3	2	4.4	0.00	1.00000	KAT8 PDIA2 RBL2
Taking other prescription medications	3.67	2	0	0.0	0.00	1.00000	HTT RBL2
Bipolar Disorder or Schizophrenia	3.63	2	1	2.2	0.00	1.00000	FCF1P2 FES
Forced expiratory volume in 1-second (FEV1), Best measure	3.63	3	1	2.2	0.00	1.00000	HTT KAT8 RBL2
Schizophrenia (2014)	3.60	1	1	2.2	0.00	1.00000	FES
Forced vital capacity (FVC), Best measure	3.60	3	1	2.2	0.00	1.00000	HTT KAT8 RBL2
Medication: Co-codamol	3.45	1	0	0.0	0.00	1.00000	KAT8
Arm fat-free mass (left)	3.43	3	2	4.4	0.00	1.00000	KAT8 PDIA2 RBL2
Arm predicted mass (left)	3.43	3	2	4.4	0.00	1.00000	KAT8 PDIA2 RBL2
Pack years of smoking	3.34	1	0	0.0	0.00	1.00000	FCF1P2
Medication: Ramipril	3.33	1	0	0.0	0.00	1.00000	FES
Qualifications: None of the above	3.32	1	1	2.2	0.00	1.00000	RBL2
Hearing difficulty/problems: Yes	3.30	2	0	0.0	0.00	1.00000	HTT RBL2
Number of full brothers	3.30	1	0	0.0	0.00	1.00000	PDIA2
Arm fat-free mass (right)	3.21	3	2	4.4	0.00	1.00000	KAT8 PDIA2 RBL2
Diabetes (mother)	3.19	1	0	0.0	0.00	1.00000	RBL2
Pulse rate, automated reading	3.18	2	1	2.2	0.00	1.00000	HTT RBL2
Pack years adult smoking proportion	3.17	1	0	0.0	0.00	1.00000	FCF1P2
Maternal smoking around birth	3.16	1	0	0.0	0.00	1.00000	PDIA2
Alcohol usually taken with meals	3.15	2	0	0.0	0.00	1.00000	FES RBL2
Forced expiratory volume in 1-second (FEV1), predicted percentage	3.13	1	1	2.2	0.00	1.00000	KAT8
Townsend deprivation index at recruitment	3.11	1	0	0.0	0.00	1.00000	KAT8
Comparative body size at age 10	3.09	3	0	0.0	0.00	1.00000	HTT KAT8 PDIA2
Arm predicted mass (right)	3.07	3	2	4.4	0.00	1.00000	KAT8 PDIA2 RBL2
Alzheimer’s Disease (in mother)	3.05	1	0	0.0	0.00	1.00000	KAT8
Serious illness, injury or assault to yourself	3.01	1	0	0.0	0.00	1.00000	PDIA2
Tense / 'highly strung'	3.01	2	0	0.0	0.00	1.00000	FCF1P2 KAT8
Trunk fat-free mass	2.97	2	1	2.2	0.00	1.00000	KAT8 RBL2
Trunk predicted mass	2.97	2	1	2.2	0.00	1.00000	KAT8 RBL2
Current tobacco smoking	2.95	1	0	0.0	0.00	1.00000	FES
Average weekly champagne plus white wine intake	2.90	2	0	0.0	0.00	1.00000	HTT RBL2
Qualifications: A levels/AS levels or equivalent	2.85	2	0	0.0	0.00	1.00000	PDIA2 RBL2
Mother's age at death	2.85	1	0	0.0	0.00	1.00000	PDIA2
Forced vital capacity (FVC)	2.80	3	0	0.0	0.00	1.00000	HTT KAT8 RBL2
Exposure to tobacco smoke outside home	2.80	1	0	0.0	0.00	1.00000	KAT8
Noisy workplace	2.78	1	0	0.0	0.00	1.00000	PDIA2
Impedance of whole body	2.78	4	1	2.2	0.19	0.80932	FES KAT8 PDIA2 RBL2
Sitting height	2.77	2	1	2.2	0.00	1.00000	FES RBL2
Medication: Lansoprazole	2.70	1	0	0.0	0.00	1.00000	RBL2
Medication for pain relief, constipation, heartburn	2.65	1	0	0.0	0.00	1.00000	PDIA2
Respiratory disease	2.64	2	0	0.0	0.00	1.00000	FES HTT
Sensitivity / hurt feelings	2.63	1	0	0.0	0.00	1.00000	FES
Headache pain in last month	2.63	1	0	0.0	0.00	1.00000	FES
Body Mass Index (BMI) (2010)	2.62	1	0	0.0	0.00	1.00000	PDIA2
Blood White Count	2.62	4	3	6.7	-0.63	0.37072	FCF1P2 FES HTT KAT8
Forced expiratory volume in 1-second (FEV1)	2.60	3	0	0.0	0.00	1.00000	HTT KAT8 RBL2
Pulse rate	2.56	1	0	0.0	0.00	1.00000	RBL2
Pain all over the body in last month	2.54	1	0	0.0	0.00	1.00000	FCF1P2
Smoking Status	2.52	1	0	0.0	0.00	1.00000	FES
Medication: Atorvastatin	2.52	1	0	0.0	0.00	1.00000	KAT8
Hearing aid user	2.48	1	0	0.0	0.00	1.00000	HTT
Alcohol drinker status: Previous	2.48	1	0	0.0	0.00	1.00000	HTT
Waist Hip Ratio (WHR)	2.47	1	1	2.2	0.00	1.00000	RBL2
Chest pain or discomfort	2.46	1	0	0.0	0.00	1.00000	HTT
Qualifications: nursing, teaching	2.46	1	0	0.0	0.00	1.00000	RBL2
Frequency of tiredness / lethargy in last 2 weeks	2.42	1	0	0.0	0.00	1.00000	HTT
Age at last live birth	2.41	1	0	0.0	0.00	1.00000	HTT
Lung cancer (father)	2.40	1	0	0.0	0.00	1.00000	FES
Handedness (chirality/laterality): Left-handed	2.40	1	0	0.0	0.00	1.00000	FES
Allergy	2.39	3	0	0.0	0.00	1.00000	FCF1P2 FES HTT
Hypothyroidism (self reported)	2.38	1	0	0.0	0.00	1.00000	FCF1P2
Standing height	2.38	2	1	2.2	0.00	1.00000	HTT RBL2
Breastfed as a baby	2.31	1	0	0.0	0.00	1.00000	FES
Asthma (self-reported)	2.30	1	0	0.0	0.00	1.00000	HTT
Medication: Metformin	2.29	1	0	0.0	0.00	1.00000	RBL2
Irritability	2.23	1	0	0.0	0.00	1.00000	KAT8
Mean time to correctly identify matches	2.22	2	0	0.0	0.00	1.00000	FES HTT
Medication: Paracetamol	2.21	1	0	0.0	0.00	1.00000	KAT8
Height	2.20	4	1	2.2	0.76	0.24422	FCF1P2 FES HTT RBL2
Medication: Omeprazole	2.20	1	0	0.0	0.00	1.00000	RBL2
Worry (Nagel 2018)	2.19	2	0	0.0	0.00	1.00000	FCF1P2 KAT8
Frequency of tenseness / restlessness in last 2 weeks	2.17	1	0	0.0	0.00	1.00000	HTT
Asthma	2.17	1	0	0.0	0.00	1.00000	HTT
Qualifications: O levels/GCSEs or equivalent	2.15	1	0	0.0	0.00	1.00000	RBL2
Crohns Disease (2017)	2.14	2	0	0.0	0.00	1.00000	FES RBL2
Hypothyroidism/myxoedema (self-reported)	2.14	1	0	0.0	0.00	1.00000	FCF1P2
Smoking status: Current	2.14	1	0	0.0	0.00	1.00000	FES
Nervous feelings	2.12	1	0	0.0	0.00	1.00000	KAT8
Ever had stillbirth, spontaneous miscarriage or termination	2.11	1	0	0.0	0.00	1.00000	FES
Hand grip strength (right)	2.10	2	0	0.0	0.00	1.00000	KAT8 RBL2
Stomach or abdominal pain in last month	2.10	1	0	0.0	0.00	1.00000	PDIA2
Qualifications: NVQ or HND or HNC or equivalent	2.10	1	0	0.0	0.00	1.00000	HTT
Hand grip strength (left)	2.01	2	0	0.0	0.00	1.00000	FES KAT8
Blood Red Count	2.00	4	2	4.4	-0.37	0.62732	FCF1P2 FES KAT8 PDIA2
Lung FVC	1.99	2	1	2.2	0.00	1.00000	HTT KAT8
Worry too long after embarrassment	1.97	1	0	0.0	0.00	1.00000	HTT
Heart disease (mother)	1.96	1	0	0.0	0.00	1.00000	FES
Comparative height size at age 10	1.93	2	1	2.2	0.00	1.00000	FES RBL2
Impedance of arm (right)	1.91	2	1	2.2	0.00	1.00000	KAT8 PDIA2
Back pain experienced in last month	1.90	1	0	0.0	0.00	1.00000	PDIA2
Neuroticism	1.88	1	0	0.0	0.00	1.00000	KAT8
HDL Cholesterol	1.86	1	0	0.0	0.00	1.00000	KAT8
Severe depression (siblings)	1.86	1	0	0.0	0.00	1.00000	FES
Impedance of arm (left)	1.85	1	1	2.2	0.00	1.00000	KAT8
Osteoarthritis (self-reported)	1.83	1	0	0.0	0.00	1.00000	RBL2
Medication: Levothyroxine sodium	1.81	1	0	0.0	0.00	1.00000	FCF1P2
Irritable Bowel Disease (IBD)	1.77	1	0	0.0	0.00	1.00000	FES
Hearing difficulty/problems with background noise	1.77	1	0	0.0	0.00	1.00000	RBL2
Crohns Disease (2012)	1.74	1	0	0.0	0.00	1.00000	FES
Age started oral contraceptive pill	1.73	1	0	0.0	0.00	1.00000	FES
Commuting to job workplace: Car/motor vehicle	1.67	1	0	0.0	0.00	1.00000	FCF1P2
Ever smoked	1.64	1	0	0.0	0.00	1.00000	FES
Loneliness, isolation	1.61	1	0	0.0	0.00	1.00000	HTT
Reaction Time	1.56	2	0	0.0	0.00	1.00000	FES HTT
Allergy or Eczema	1.54	1	0	0.0	0.00	1.00000	FES
Peak expiratory flow (PEF)	1.53	1	0	0.0	0.00	1.00000	RBL2
Ovarian Cancer	1.51	1	0	0.0	0.00	1.00000	FES
Breast Cancer	1.49	1	0	0.0	0.00	1.00000	FES
Neuroticism (Nagel 2018)	1.48	1	0	0.0	0.00	1.00000	KAT8
Age when periods started (menarche)	1.47	1	0	0.0	0.00	1.00000	HTT
Depression (Nagel 2018)	1.42	1	0	0.0	0.00	1.00000	HTT
Forced expiratory volume in 1-second (FEV1), predicted	1.38	1	0	0.0	0.00	1.00000	RBL2
Risk taking	1.34	1	0	0.0	0.00	1.00000	FES
Heel T-Score	1.19	1	1	2.2	0.00	1.00000	KAT8
Past tobacco smoking	1.17	1	0	0.0	0.00	1.00000	FES
Blood Eosinophil Count	1.08	1	1	2.2	0.00	1.00000	KAT8
Chronotype (morning person)	0.84	1	0	0.0	0.00	1.00000	HTT
Hair/balding pattern: Pattern 4	0.83	1	0	0.0	0.00	1.00000	FES
Lung FEV1/FVC ratio	0.73	1	0	0.0	0.00	1.00000	KAT8
Hair Pigment	0.32	1	1	2.2	0.00	1.00000	FES
Blood Platelet Count	0.26	1	0	0.0	0.00	1.00000	RBL2

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Brain Cortex	1	0.097	1.6
GTEx	Brain Frontal Cortex BA9	0	0.000	1.6
GTEx	Brain Hippocampus	0	0.000	1.6
GTEx	Ovary	0	0.000	1.6
GTEx	Prostate	0	0.000	1.6
GTEx	Stomach	0	0.000	1.6
GTEx	Adipose Subcutaneous	1	0.029	1.5
GTEx	Adipose Visceral Omentum	1	0.049	1.5
GTEx	Artery Aorta	0	0.000	1.5
GTEx	Artery Coronary	0	0.000	1.5
GTEx	Brain Caudate basal ganglia	0	0.000	1.5
GTEx	Brain Cerebellar Hemisphere	0	0.000	1.5
GTEx	Brain Cerebellum	0	0.000	1.5
GTEx	Brain Nucleus accumbens basal ganglia	0	0.000	1.5
GTEx	Brain Putamen basal ganglia	0	0.000	1.5
GTEx	Breast Mammary Tissue	0	0.000	1.5
GTEx	Breast Mammary Tissue (Female)	0	0.000	1.5
GTEx	Colon Transverse	0	0.000	1.5
GTEx	Esophagus Gastroesophageal Junction	0	0.000	1.5
GTEx	Heart Left Ventricle	0	0.000	1.5
GTEx	Muscle Skeletal	0	0.000	1.5
GTEx	Pancreas	0	0.000	1.5
GTEx	Pituitary	0	0.000	1.5
GTEx	Skin Not Sun Exposed Suprapubic	0	0.000	1.5
GTEx	Skin Sun Exposed Lower leg	0	0.000	1.5
GTEx	Small Intestine Terminal Ileum	0	0.000	1.5
GTEx	Thyroid	0	0.000	1.5
GTEx	Uterus	0	0.000	1.5
GTEx	Whole Blood	2	0.100	1.5
GTEx	Adrenal Gland	0	0.000	1.4
GTEx	Artery Tibial	0	0.000	1.4
GTEx	Brain Hypothalamus	0	0.000	1.4
GTEx	Breast Mammary Tissue (Male)	0	0.000	1.4
GTEx	Cells EBV-transformed lymphocytes	0	0.000	1.4
GTEx	Cells Transformed fibroblasts	0	0.000	1.4
GTEx	Colon Sigmoid	0	0.000	1.4
GTEx	Esophagus Mucosa	0	0.000	1.4
GTEx	Esophagus Muscularis	0	0.000	1.4
GTEx	Heart Atrial Appendage	0	0.000	1.4
GTEx	Liver	0	0.000	1.4
GTEx	Lung	0	0.000	1.4
GTEx	Nerve Tibial	0	0.000	1.4
GTEx	Spleen	0	0.000	1.4
GTEx	Testis	0	0.000	1.4
METSIM	Adipose	0	0.000	1.4
ROSMAP	Brain Pre-frontal Cortex	1	0.023	1.4
YFS	Blood	0	0.000	1.4
The Cancer Genome Atlas	Esophageal Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Glioblastoma Multiforme	0	0.000	1.4
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	0	0.000	1.4
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	1	0.060	1.4
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	0	0.000	1.4
The Cancer Genome Atlas	Stomach Adenocarcinoma	0	0.000	1.4
The Cancer Genome Atlas	Thyroid Carcinoma	0	0.000	1.4
GTEx	Vagina	0	0.000	1.3
NTR	Blood	0	0.000	1.3
CommonMind	Brain Pre-frontal Cortex	0	0.000	1.3
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	0	0.000	1.3
The Cancer Genome Atlas	Breast Invasive Carcinoma	1	0.023	1.3
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	0	0.000	1.3
The Cancer Genome Atlas	Colon Adenocarcinoma	0	0.000	1.3
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	0	0.000	1.3
The Cancer Genome Atlas	Brain Lower Grade Glioma	0	0.000	1.3
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	0	0.000	1.3
The Cancer Genome Atlas	Lung Adenocarcinoma	0	0.000	1.3
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	0	0.000	1.3
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	0	0.000	1.3
The Cancer Genome Atlas	Prostate Adenocarcinoma	1	0.022	1.3
The Cancer Genome Atlas	Rectum Adenocarcinoma	0	0.000	1.3
The Cancer Genome Atlas	Soft Tissue Sarcoma	0	0.000	1.3
The Cancer Genome Atlas	Skin Cutaneous Melanoma	0	0.000	1.3
The Cancer Genome Atlas	Testicular Germ Cell Tumors	0	0.000	1.3
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	0	0.000	1.2